This volume investigates the clinical paradox regarding the efficacy of bisphosphonates in relation to varying levels of bone mineral density in high-risk patients. Authors Cyrus Cooper and Stephen H. Gehlbach synthesize findings from recent clinical trials to address why treatment efficacy appears to diminish as bone mineral density increases. By examining the physiological and pharmacological mechanisms at play, the text provides a framework for practitioners to better understand and manage osteoporosis in vulnerable populations.

Medical professionals and researchers utilize this text as a specialized resource for understanding the nuances of osteoporosis management. Experts highlight the book's focus on reconciling clinical trial data with practical patient care strategies.